290 related articles for article (PubMed ID: 34670781)
41. Oxidative demethylase ALKBH5 repairs DNA alkylation damage and protects against alkylation-induced toxicity.
Akula D; O'Connor TR; Anindya R
Biochem Biophys Res Commun; 2021 Jan; 534():114-120. PubMed ID: 33321288
[TBL] [Abstract][Full Text] [Related]
42. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
[TBL] [Abstract][Full Text] [Related]
43. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
44. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
45. ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer.
An Y; Duan H
J Ovarian Res; 2024 Apr; 17(1):84. PubMed ID: 38637813
[TBL] [Abstract][Full Text] [Related]
46. The demethylase ALKBH5 mediates ZKSCAN3 expression through the m
Wang Q; Huang Y; Jiang M; Tang Y; Wang Q; Bai L; Yu C; Yang X; Ding K; Wang W; Bai J; Chen Y
J Hazard Mater; 2024 Jul; 473():134690. PubMed ID: 38781857
[TBL] [Abstract][Full Text] [Related]
47. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
48. The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
Tsukuda S; Harris JM; Magri A; Balfe P; Siddiqui A; Wing PAC; McKeating JA
PLoS Pathog; 2024 Jan; 20(1):e1011917. PubMed ID: 38227578
[TBL] [Abstract][Full Text] [Related]
49. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
50. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
[TBL] [Abstract][Full Text] [Related]
51. ALKBH5 suppresses tumor progression via an m
Yuan Y; Yan G; He M; Lei H; Li L; Wang Y; He X; Li G; Wang Q; Gao Y; Qu Z; Mei Z; Shen Z; Pu J; Wang A; Zhao W; Jiang H; Du W; Yang L
Cell Death Dis; 2021 Jan; 12(1):60. PubMed ID: 33431791
[TBL] [Abstract][Full Text] [Related]
52. FOXD3-mediated transactivation of ALKBH5 promotes neuropathic pain via m
Huang Z; Zhang Y; Wang S; Qi R; Tao Y; Sun Y; Jiang D; Jiang X; Tao J
Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2312861121. PubMed ID: 38285939
[TBL] [Abstract][Full Text] [Related]
53. ALKBH5 controls the meiosis-coupled mRNA clearance in oocytes by removing the N
Bai L; Xiang Y; Tang M; Liu S; Chen Q; Chen Q; Zhang M; Wan S; Sang Y; Li Q; Wang S; Li Z; Song Y; Hu X; Mao L; Feng G; Cui L; Ye Y; Zhu Y
Nat Commun; 2023 Oct; 14(1):6532. PubMed ID: 37848452
[TBL] [Abstract][Full Text] [Related]
54. Aging-Associated ALKBH5-m
Chen R; Zhang G; Sun K; Chen AF
J Am Heart Assoc; 2024 Jan; 13(1):e031353. PubMed ID: 38156523
[TBL] [Abstract][Full Text] [Related]
55. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
[TBL] [Abstract][Full Text] [Related]
56. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
57. N6-methyladenosine RNA demethylase ALKBH5 is testis-specifically downregulated in hybrid male sterile dzo and is a target gene of bta-miR-200a.
Chen H; Zhang J; Yan Y; Zhu C; Wang L; Fu S; Zuo F; Zhang GW
Theriogenology; 2022 Jul; 187():51-57. PubMed ID: 35504087
[TBL] [Abstract][Full Text] [Related]
58. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
59.
Purslow JA; Nguyen TT; Khatiwada B; Singh A; Venditti V
Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34407931
[TBL] [Abstract][Full Text] [Related]
60. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
